Search results
Sen. Hassan slams GlaxoSmithKline over cost of asthma inhalers
New Hampshire Union Leader· 3 days agoPharmaceutical giant GlaxoSmithKline is sidestepping its pledge to lower asthma inhaler prices, a...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Associated Press via Yahoo News· 4 days agoThe Federal Trade Commission on Tuesday sent warning...loss, diabetes, asthma and other reparatory...
GSK profit drops in first quarter on higher costs
Digital Journal· 3 days agoBritish drugmaker GlaxoSmithKline on Wednesday said its net profit fell 23 percent in the first quarter as the company faced higher exceptional costs...
FTC challenges ‘bogus’ patents on Ozempic, other drugs that ‘block competition’
Market Watch· 4 days agoFederal regulators are challenging patents on 20 brand-name drugs, including the blockbuster...
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
CNBC· 4 days agoThe Federal Trade Commission on Tuesday said it is challenging hundreds of alleged "junk" patents...
Janssen adopts J&J name as part of global rebranding effort
Pharmaceutical Technology via Yahoo Finance· 3 days agoOver the past 100 years, our first responsibility has always been to the patients...unveiled a new...
FTC Warns ‘Junk Patents’ Could Make Drugs Like Ozempic Pricier—Here’s How
Forbes· 5 days agoThe FTC sent warning letters to 10 pharmaceutical companies—including Novo Nordisk, AstraZeneca, ...
5 best blue chip stocks to invest in for sustainable gains in May - excluding Apple Inc. (AAPL) |...
Invezz· 1 day agoYesterday, the biggest company in the world in terms of market cap reported its latest earnings....
Star Scientist’s Claim of ‘Reverse Aging’ Draws Hail of Criticism
The Wall Street Journal· 7 days agoHis lab there found that resveratrol appeared to prolong the lifespan of mice. Sinclair was one of...